Tower Research Capital (TRC)’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$252K Buy
8,305
+7,178
+637% +$191K 0.01% 1436
2025
Q4
$32.5K Sell
1,127
-3,126
-74% -$40.8K ﹤0.01% 2747
2025
Q3
$30.7K Sell
4,253
-2,495
-37% -$18.4K ﹤0.01% 2917
2025
Q2
$67K Buy
6,748
+4,976
+281% +$52.6K ﹤0.01% 2720
2025
Q1
$16.8K Sell
1,772
-4,425
-71% -$61.4K ﹤0.01% 3142
2024
Q4
$85.5K Sell
6,197
-17,627
-74% -$309K ﹤0.01% 2239
2024
Q3
$362K Buy
23,824
+14,300
+150% +$70.7K 0.01% 1097
2024
Q2
$45.4K Buy
9,524
+4,691
+97% +$26.2K ﹤0.01% 3182
2024
Q1
$32.8K Buy
4,833
+3,473
+255% +$16.8K ﹤0.01% 2579
2023
Q4
$6.65K Sell
1,360
-7,562
-85% -$24.6K ﹤0.01% 4716
2023
Q3
$30.5K Sell
8,922
-3,314
-27% -$18.6K ﹤0.01% 3007
2023
Q2
$58.5K Buy
12,236
+3,466
+40% +$15.2K ﹤0.01% 2467
2023
Q1
$37K Buy
8,770
+5,096
+139% +$21.9K ﹤0.01% 2777
2022
Q4
$14K Buy
+3,674
New +$17.5K ﹤0.01% 3492
2022
Q3
Sell
-1,684
Closed -$5K 6087
2022
Q2
$5K Buy
+1,684
New +$5.98K ﹤0.01% 5036
2022
Q1
Sell
-1,277
Closed -$4K 6116
2021
Q4
$4K Buy
1,277
+1,259
+6,994% +$4.41K ﹤0.01% 5283
2021
Q3
$0 Sell
18
-14,284
-100% -$65K ﹤0.01% 5787
2021
Q2
$73K Buy
14,302
+7,109
+99% +$30.1K ﹤0.01% 2686
2021
Q1
$34K Buy
7,193
+6,171
+604% +$35.5K ﹤0.01% 3441
2020
Q4
$4K Buy
+1,022
New +$4.43K ﹤0.01% 4689
2016
Q4
Sell
-57
Closed -$2K 3840
2016
Q3
$2K Sell
57
-20
-26% -$752 ﹤0.01% 3033
2016
Q2
$3K Sell
77
-68
-47% -$2.4K ﹤0.01% 3664
2016
Q1
$4K Sell
145
-102
-41% -$2.47K ﹤0.01% 2855
2015
Q4
$8K Buy
+247
New +$9.83K ﹤0.01% 2383
2015
Q3
Sell
-2
Closed 4042
2015
Q2
$0 Hold
2
﹤0.01% 4417
2015
Q1
$0 Buy
+2
New +$173 ﹤0.01% 4419

Other funds holding CAPR